Oscar Haigh

Oscar Haigh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Oscar Haigh has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Marc Labetoulle

    Service d'Ophtalmologie, Hôpital Bicêtre, CRMR OPHTARA, Université Paris-Saclay, Le Kremlin Bicêtre, France; IMVA-HB/U1184, Infrastructure nationale IDMIT, Fontenay-Aux-Roses, France; Ophthalmology Department III, Quinze-Vingts National Vision Hospital, Paris, France

    2 shared publications
  • Antoine Rousseau

    Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB), Commissariat à l’énergie Atomique et Aux Énergies Renouvelables, Université Paris-Saclay, INSERM U1184, Fontenay-aux-Roses, France

    1 shared publication
  • Antoine Rousseau

    Department of Ophthalmology, Hôpital National des Quinze-Vingts, IHU FOReSIGHT, 75012 Paris, France

    1 shared publication
  • Claire Deback

    Service de Virologie, Hôpital Paul Brousse, Université Paris-Saclay, APHP, Villejuif, France

    1 shared publication
  • Emma J. Grant

    Infection and Immunity Program, La Trobe Institute for Molecular Science (LIMS) La Trobe University Bundoora VIC Australia

    1 shared publication
  • Imen Ksiaa

    Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia

    1 shared publication

Latest Publications

  • Open Access

    Initial TK-deficient HSV-1 infection in the lip alters contralateral lip challenge immune dynamics

    by Antoine Rousseau, Oscar Haigh, Roger Legrand, Jean-Louis Palgen, Julien Lemaitre, Claire Deback, Noémie Oziol, Patrick Lomonte, Marc Labetoulle

    Primary infection with herpes simplex type 1 (HSV-1) occurring around the mouth and nose switches rapidly to lifelong latent infection in sensitive trigeminal ganglia (TG) neurons. Sporadic reactivation of these latent reservoirs later in life is the cause of acute infections of the corneal epithelium, which can cause potentially blinding herpes simplex keratitis (HSK). There is no effective vaccine to protect against HSK, and antiviral drugs provide only partial protection against recurrences. We previously engendered an acute disease-free, non-reactivating latent state in mice when challenged with virulent HSV-1 in orofacial mucosa, by priming with non-neurovirulent HSV-1 (TKdel) before the challenge. Herein, we define the local immune infiltration and inflammatory chemokine production changes after virulent HSV-1 challenge, which were elicited by TKdelprime. Heightened immunosurveillance before virulent challenge, and early enhanced lymphocyte-enriched infiltration of the challenged lip were induced, which corresponded to attenuation of inflammation in the TG and enhanced viral control. Furthermore, classical latent-phase T cell persistence around latent HSV-1 reservoirs were severely reduced. These findings identify the immune processes that are likely to be responsible for establishing non-reactivating latent HSV-1 reservoirs. Stopping reactivation is essential for development of efficient vaccine strategies against HSV-1.


  • Open Access

    Genetic Bias, Diversity Indices, Physiochemical Properties and CDR3 Motifs Divide Auto-Reactive from Allo-Reactive T-Cell Repertoires

    by Oscar L. Haigh, Emma J. Grant, Thi H. O. Nguyen, Katherine Kedzierska, Matt A. Field, John J. Miles

    The distinct properties of allo-reactive T-cell repertoires are not well understood. To investigate whether auto-reactive and allo-reactive T-cell repertoires encoded distinct properties, we used dextramer enumeration, enrichment, single-cell T-cell receptor (TCR) sequencing and multiparameter analysis. We found auto-reactive and allo-reactive T-cells differed in mean ex vivo frequency which was antigen dependent. Allo-reactive T-cells showed clear differences in TCR architecture, with enriched usage of specific T-cell receptor variable (TRBJ) genes and broader use of T-cell receptor variable joining (TRBJ) genes. Auto-reactive T-cell repertoires exhibited complementary determining regions three (CDR3) lengths using a Gaussian distribution whereas allo-reactive T-cell repertoires exhibited distorted patterns in CDR3 length. CDR3 loops from allo-reactive T-cells showed distinct physical-chemical properties, tending to encode loops that were more acidic in charge. Allo-reactive T-cell repertoires differed in diversity metrics, tending to show increased overall diversity and increased homogeneity between repertoires. Motif analysis of CDR3 loops showed allo-reactive T-cell repertoires differed in motif preference which included broader motif use. Collectively, these data conclude that allo-reactive T-cell repertoires are indeed different to auto-reactive repertoires and provide tangible metrics for further investigations and validation. Given that the antigens studied here are overexpressed on multiple cancers and that allo-reactive TCRs often show increased ligand affinity, this new TCR bank also has translational potential for adoptive cell therapy, soluble TCR-based therapy and rational TCR design.


  • Open Access

    Ocular Manifestations of West Nile Virus

    by Antoine Rousseau, Oscar Haigh, Imen Ksiaa, Moncef Khairallah, Marc Labetoulle

    Ocular manifestations are a feature of West Nile virus infection. They mostly occur in association with severe neuroinvasive disease. Linear chorioretinitis is suggestive of the diagnosis and may raise diagnostic suspicion when associated with evocative systemic signs, and in an epidemic context. Various other less specific inflammatory ocular manifestations have been reported, including anterior uveitis, occlusive retinal vasculitis, optic neuritis, and diplopia. The pathophysiology of ocular disease remains unclear, but it reflects the neuroinvasiveness of the disease. Although ocular involvement most often resolves without visual sequelae, some patients may have permanent loss of vision, adding to the need for the development of a specific treatment and/or vaccines.